
CL
Colgate-Palmolive Co
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
84.750
Open
84.520
VWAP
83.67
Vol
5.05M
Mkt Cap
67.74B
Low
82.650
Amount
422.38M
EV/EBITDA(TTM)
15.38
Total Shares
820.44M
EV
75.90B
EV/OCF(TTM)
19.36
P/S(TTM)
3.45
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
5.20B
+5.88%
0.971
+6.65%
5.20B
+5.16%
0.946
+3.93%
5.18B
+3.01%
0.906
-0.43%
Estimates Revision
The market is revising Upward the revenue expectations for Colgate-Palmolive Company (CL) for FY2025, with the revenue forecasts being adjusted by 0.53% over the past three months. During the same period, the stock price has changed by -7.51%.
Revenue Estimates for FY2025
Revise Upward

+0.53%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+0.34%
In Past 3 Month
Stock Price
Go Down

-7.51%
In Past 3 Month
13 Analyst Rating

16.93% Upside
Wall Street analysts forecast CL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CL is 98.00 USD with a low forecast of 83.00 USD and a high forecast of 109.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
3 Hold
1 Sell
Moderate Buy

16.93% Upside
Current: 83.810

Low
83.00
Averages
98.00
High
109.00

16.93% Upside
Current: 83.810

Low
83.00
Averages
98.00
High
109.00
TD Cowen
Buy
downgrade
$100 -> $90
2025-08-06
Reason
TD Cowen
Price Target
$100 -> $90
2025-08-06
downgrade
Buy
Reason
TD Cowen lowered the firm's price target on Colgate-Palmolive to $90 from $100 and keeps a Buy rating on the shares. The firm said 2Q was broadly in line, but management tamped down sales guidance to the lower end of the 2-4% range. In addition, as part of their new 2030 Strategic Plan, they announced a three-year restructuring program to optimize the supply chain and streamline the organization.
Wells Fargo
Underweight
downgrade
$88 -> $83
2025-08-04
Reason
Wells Fargo
Price Target
$88 -> $83
2025-08-04
downgrade
Underweight
Reason
Wells Fargo lowered the firm's price target on Colgate-Palmolive to $83 from $88 and keeps an Underweight rating on the shares. Despite an improving USD, typically a boon for Colgate-Palmolive, estimates are unchanged as the backdrop weighs, the firm says. Debates from here will be an implied sales acceleration into the second half of the year and building blocks for 2026. It is unclear if the stock gets much life pending clarity here, Wells adds.
Morgan Stanley
Overweight
downgrade
$104 -> $96
2025-08-04
Reason
Morgan Stanley
Price Target
$104 -> $96
2025-08-04
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Colgate-Palmolive to $96 from $104 and keeps an Overweight rating on the shares. Q2 results "should do little to change the debate on Colgate," according to the analyst, who favors Coca-Cola (KO), Keurig Dr Pepper (KDP), Philip Morris (PM) and Monster Beverage (MNST) outside of health and personal care. However, Colgate remains a "relative" Overweight within household products, the analyst contends.
Citi
Buy
maintain
$108 -> $105
2025-08-03
Reason
Citi
Price Target
$108 -> $105
2025-08-03
maintain
Buy
Reason
Citi lowered the firm's price target on Colgate-Palmolive to $105 from $108 and keeps a Buy rating on the shares. The company reported a "subdued" Q2 but its outlook for 2025 is conservative, the analyst tells investors in a research note. The firm slightly reduced estimates post the earnings print.
Jefferies
Hold
maintain
$94 -> $95
2025-08-01
Reason
Jefferies
Price Target
$94 -> $95
2025-08-01
maintain
Hold
Reason
Jefferies raised the firm's price target on Colgate-Palmolive to $95 from $94 and keeps a Hold rating on the shares following a "decent" Q2 earning beat. The strategy is working and the new productivity plan is a positive, but the backdrop remains tough, Jefferies told investors. The firm added that there are a lot of moving parts, keeping expectations for upside at bay.
JPMorgan
Overweight
downgrade
$103 -> $99
2025-07-25
Reason
JPMorgan
Price Target
$103 -> $99
2025-07-25
downgrade
Overweight
Reason
JPMorgan lowered the firm's price target on Colgate-Palmolive to $99 from $103 and keeps an Overweight rating on the shares as part of a quarterly earnings preview. The firm expects another challenging quarter for most names in the household and personal care sector.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Colgate-Palmolive Co (CL.N) is 22.19, compared to its 5-year average forward P/E of 24.61. For a more detailed relative valuation and DCF analysis to assess Colgate-Palmolive Co 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
24.61
Current PE
22.19
Overvalued PE
26.19
Undervalued PE
23.04
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
16.16
Current EV/EBITDA
14.74
Overvalued EV/EBITDA
17.04
Undervalued EV/EBITDA
15.28
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued
5Y Average PS
3.63
Current PS
3.25
Overvalued PS
3.95
Undervalued PS
3.31
Financials
Annual
Quarterly
FY2025Q2
YoY :
+1.03%
5.11B
Total Revenue
FY2025Q2
YoY :
-1.89%
1.09B
Operating Profit
FY2025Q2
YoY :
+0.78%
773.00M
Net Income after Tax
FY2025Q2
YoY :
+2.25%
0.91
EPS - Diluted
FY2025Q2
YoY :
-11.11%
776.00M
Free Cash Flow
FY2025Q2
YoY :
-0.92%
60.06
Gross Profit Margin - %
FY2025Q2
YoY :
+0.30%
16.85
FCF Margin - %
FY2025Q2
YoY :
-0.20%
15.13
Net Margin - %
FY2025Q2
YoY :
+3.39%
34.14
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
200.2K
USD
1
6-9
Months
736.1K
USD
1
0-12
Months
6.5M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
5.1K
Volume
1
3-6
Months
979.0K
Volume
13
6-9
Months
915.4K
Volume
12
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
5
164.9K
Volume
Months
6-9
9
1.2M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areBuying! The buying amount has increased100%over the last month.
Sold
0-3
Months
24.0K
USD
3
3-6
Months
16.0K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
4
32.0K
USD
Months
3-6
4
32.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
200.2K
USD
1
6-9
Months
736.1K
USD
1
0-12
Months
6.5M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CL News & Events
Events Timeline
2025-08-01 (ET)
2025-08-01
06:58:09
Colgate-Palmolive reports Q2 GAAP gross profit margin decreased 50 basis points

2025-08-01
06:57:11
Colgate-Palmolive backs FY25 net sales up low single digits

2025-08-01
06:56:11
Colgate-Palmolive announces new three-year productivity program

Sign Up For More Events
Sign Up For More Events
News
7.0
09-02TipRanksColgate-Palmolive (CL) Reaches $332 Million Settlement in Pension Class-Action Lawsuit
7.0
09-02ReutersColgate-Palmolive Agrees to $332 Million Settlement with Workers Regarding Pension Issues
8.0
09-01Yahoo FinanceTrump announces India will reduce tariffs following U.S. increase on Russian oil duties.
Sign Up For More News
People Also Watch

APD
Air Products and Chemicals Inc
291.280
USD
-0.31%

ET
Energy Transfer LP
17.570
USD
-0.73%

WMB
Williams Companies Inc
57.730
USD
+0.61%

EMR
Emerson Electric Co
129.500
USD
-1.43%

FTNT
Fortinet Inc
76.580
USD
-0.45%

CP
Canadian Pacific Kansas City Ltd
76.680
USD
+0.33%

NOC
Northrop Grumman Corp
581.010
USD
-1.41%

BMO
Bank of Montreal
123.540
USD
+1.53%

TRI
Thomson Reuters Corp
177.500
USD
-0.08%

ORLY
O'Reilly Automotive Inc
103.840
USD
+0.63%
FAQ

What is Colgate-Palmolive Co (CL) stock price today?
The current price of CL is 83.81 USD — it has decreased -0.69 % in the last trading day.

What is Colgate-Palmolive Co (CL)'s business?

What is the price predicton of CL Stock?

What is Colgate-Palmolive Co (CL)'s revenue for the last quarter?

What is Colgate-Palmolive Co (CL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Colgate-Palmolive Co (CL)'s fundamentals?

How many employees does Colgate-Palmolive Co (CL). have?
